Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(17/week)
News
United States
(592/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Monoclonal antibodies
Oct 26, 2017
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis
Oct 26, 2017
Risankizumab Meets All Co-Primary and Ranked Secondary Endpoints, Achieving Significantly Greater Efficacy Versus Standard Biologic Therapies in Three Pivotal Phase 3 Psoriasis Studies
Oct 25, 2017
Nail psoriasis data now part of HUMIRA® label
Oct 25, 2017
Deeper than just skin, World Psoriasis Day spotlights the disease's human impact
Oct 24, 2017
AbbVie to Showcase Robust Immunology Portfolio with New and Late-Breaking Data at the 2017 ACR/ARHP Annual Meeting
Oct 24, 2017
DRG launches Patient Profiler, dramatically advancing the understanding of patient-level drivers in rheumatoid arthritis
Oct 24, 2017
MabVax Therapeutics Expands Intellectual Property Estate by Filing a New Patent Application on its Fully-Human Antibody Discoveries
Oct 20, 2017
Pursuing Novel Pathways in Immunology: Merck KGaA, Darmstadt, Germany Presents New Clinical Data at 2017 ACR/ARHP Annual Meeting
Oct 18, 2017
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis
Oct 17, 2017
ProMIS Neurosciences Lead Product Candidate, PMN310, Shows Desired Target Binding Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies for Alzheimer's Disease
Oct 17, 2017
Study Results of ACT-101 in a Model of Inflammatory Bowel Disease (IBD) Presented at the World Congress of Gastroenterology 2017
Oct 16, 2017
Despite Rheumatologist Reports that BMS' Orencia is Their Preferred Non-TNF Agent for Treating Rheumatoid Arthritis, Pfizer's Xeljanz Provides Steep Competition in Actual Switching Patterns
Oct 16, 2017
Regeneron and Sanofi Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis
Oct 16, 2017
New Post-Hoc Analyses Report Early Symptomatic Improvement in Moderately to Severely Active Ulcerative Colitis or Crohn's Disease Patients Taking Entyvio® (vedolizumab), Particularly in Biologic-Naïve Patients
Oct 13, 2017
Janssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis
Oct 12, 2017
Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ(TM) (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
Oct 12, 2017
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030
Oct 12, 2017
Global $41 Bn Respiratory Drugs Market to 2023 - Leading Players are GSK, AstraZeneca and Boehringer Ingelheim
Oct 12, 2017
Mirati Therapeutics' Mocetinostat Included In Stand Up To Cancer's Cutting-Edge Clinical Trial Initiative For NSCLC Patients
Oct 11, 2017
Global Bispecific Antibody Therapeutics Market, 2017-2030 - Overall Pipeline Comprises of 200+ Molecules
‹‹
Page 43
››
Latest News
Apr 24, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter 2024 Financial Results on Tuesday, May 7
Apr 24, 2024
Encore Wire Reports First Quarter Results
Apr 24, 2024
Novo Oil & Gas II Receives Equity Capital Commitment from EnCap Investments
Apr 24, 2024
Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K
Apr 24, 2024
Ranger Energy Services, Inc. Announces Date for First Quarter 2024 Earnings Conference Call
Apr 24, 2024
Crescent Energy Schedules First Quarter 2024 Earnings Release and Conference Call
Apr 24, 2024
American States Water Company to Report First Quarter 2024 Results
Apr 24, 2024
Seadrill Announces First Quarter 2024 Earnings Release and Conference Call
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events